Aktieselskabet Schouw & Co.
Schouw & Co. has for a number of years operated a share‐based incentive programme for the purpose of promoting value creation in Schouw & Co. by aligning the interests of the individuals comprised by the programme and the company's shareholders.
Under the programme, the Board of Directors has resolved to award 403,000 share options on the following terms:
The members of the Management Board of Schouw & Co., President Jens Bjerg Sørensen and Vice President Peter Kjær, will be granted 30,000 and 10,000 share options, respectively. Other senior executives, including managers of subsidiaries, comprising 30 persons, will be granted a total of 363,000 share options.
The options are exercisable during a period of 13 months following the publication of the Schouw & Co. Group's Annual Report for the 2023 financial year.
Each share option entitles the holder to purchase one Schouw & Co. share of DKK 10 nominal value. The exercise price is equal to the average official closing share price during the first five business days after the publication of the Schouw & Co. Group’s Annual Report for the 2020 financial year (of DKK 666.40), plus a premium of 2% p.a. with effect from 12 March 2021. The exercise price is adjusted less ordinary dividends, which, however, cannot exceed the accrued premium.
The new options have an aggregate theoretical market value of approximately DKK 50.5 million, calculated on the basis of the Black & Scholes model using 12‐month historical volatility based on daily average prices (31.6%) and a risk‐free interest rate (‐0.54% p.a.).
Aktieselskabet Schouw & Co.
Jørn Ankær Thomsen, Chairman
Jens Bjerg Sørensen, President
Questions to the above should be directed to Jens Bjerg Sørensen, President, on tel. +45 8611 2222.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG25.10.2025 17:00:00 CEST | Press release
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
Jelenew25.10.2025 16:21:00 CEST | Press release
World Champion Marion Clignet’s Journey: One More Kilometer, 30 Years on the Road.
Debit My Data, Inc.24.10.2025 21:42:27 CEST | Press release
DebitMyData Addresses Global H20 Export Ban Crisis, Unveils Critical Role of the Human Energy Grid
International Dialogue Centre - KAICIID24.10.2025 18:23:17 CEST | Press release
KAICIID Convenes the 6th European Policy Dialogue Forum (EPDF) to Renew Shared Values in a Fragmented Europe
Damac Properties Dubai Co. PJSC24.10.2025 18:02:55 CEST | Press release
DAMAC Invites the World to Apply for “The Ultimate DAMAC Islander”
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
